A new trading day began on Friday, with Zymeworks BC Inc (NASDAQ: ZYME) stock price down -5.35% from the previous day of trading, before settling in for the closing price of $16.26. ZYME’s price has ranged from $7.54 to $17.70 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 264.10%. Meanwhile, its annual earnings per share averaged 23.36%. With a float of $67.03 million, this company’s outstanding shares have now reached $70.12 million.
Let’s determine the extent of company efficiency that accounts for 277 employees. In terms of profitability, gross margin is -1.54%, operating margin of -194.58%, and the pretax margin is -189.75%.
Zymeworks BC Inc (ZYME) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Zymeworks BC Inc is 2.05%, while institutional ownership is 97.19%. The most recent insider transaction that took place on Jan 05 ’24, was worth 193,849. In this transaction Chair & CEO of this company sold 18,198 shares at a rate of $10.65, taking the stock ownership to the 29,468 shares. Before that another transaction happened on Jan 08 ’24, when Company’s Chair & CEO sold 5,706 for $11.22, making the entire transaction worth $63,996. This insider now owns 23,762 shares in total.
Zymeworks BC Inc (ZYME) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.2 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 23.36% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.00% during the next five years compared to -6.52% drop over the previous five years of trading.
Zymeworks BC Inc (NASDAQ: ZYME) Trading Performance Indicators
Here are Zymeworks BC Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 4.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 16.26.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.51, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach -1.68 in one year’s time.
Technical Analysis of Zymeworks BC Inc (ZYME)
Looking closely at Zymeworks BC Inc (NASDAQ: ZYME), its last 5-days average volume was 0.56 million, which is a drop from its year-to-date volume of 0.63 million. As of the previous 9 days, the stock’s Stochastic %D was 63.20%. Additionally, its Average True Range was 0.74.
During the past 100 days, Zymeworks BC Inc’s (ZYME) raw stochastic average was set at 75.50%, which indicates a significant increase from 56.50% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 72.26% in the past 14 days, which was higher than the 41.02% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.51, while its 200-day Moving Average is $10.89. However, in the short run, Zymeworks BC Inc’s stock first resistance to watch stands at $16.09. Second resistance stands at $16.78. The third major resistance level sits at $17.33. If the price goes on to break the first support level at $14.85, it is likely to go to the next support level at $14.30. Should the price break the second support level, the third support level stands at $13.61.
Zymeworks BC Inc (NASDAQ: ZYME) Key Stats
With a market capitalization of 1.01 billion, the company has a total of 68,878K Shares Outstanding. Currently, annual sales are 76,010 K while annual income is -118,670 K. The company’s previous quarter sales were 16,000 K while its latest quarter income was -29,850 K.
